Author Question: A client is due to receive fluconazole (Diflucan) for a fungal infection. The nurse would question ... (Read 72 times)

cmoore54 · **on:** Jul 23, 2018

A client is due to receive fluconazole (Diflucan) for a fungal infection. The nurse would question an order specifying which route of administration?

Standard Text: Select all that apply.
1. By mouth
2. By intramuscular injection
3. By intravenous injection
4. By subcutaneous injection
5. Topically

Question 2

The nurse is administering amphotericin B to a client with a serious systemic fungal infection. The client is experiencing acute fever, chills, and vomiting, and complains of headache.

The nurse knows that this reaction occurs in _____ of clients and anticipates that symptoms will subside as treatment continues.
Fill in the blank with the appropriate word.

mfedorka · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

Correct Answer: 2,4,5
Rationale 1: The nurse would not question an order for this medication to be administered by mouth.
Rationale 2: The nurse should question an order for this medication to be administered by IM injection.
Rationale 3: The nurse would not question an order for this medication to be administered by IV injection.
Rationale 4: The nurse should question an order for this medication to be administered by SQ injection.
Rationale 5: The nurse should question an order for this medication to be administered topically.
Global Rationale: Fluconazole offers several advantages over other systemic antifungals. It is rapidly and completely absorbed when given PO and is also available by the IV route. It is not administered IM, SQ, or topically.

Answer to Question 2

Correct Answer: 50
Rationale: Amphotericin B can produce frequent and sometimes serious adverse effects. At the onset of therapy, as many as 50 of patients experience acute, infusion-related fever and chills, vomiting, anorexia, and headache. These symptoms usually subside as treatment continues.
Global Rationale: Amphotericin B can produce frequent and sometimes serious adverse effects. At the onset of therapy, as many as 50 of patients experience acute, infusion-related fever and chills, vomiting, anorexia, and headache. These symptoms usually subside as treatment continues.